Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Feb 1;36(2):305-315.
doi: 10.1097/QAD.0000000000003109.

HIV care outcomes among transgender persons with HIV infection in the United States, 2006-2021

Jeffrey S Becasen  1 , Joseph D Morris  2 , Christa L Denard  3 , Mary M Mullins  1 , Krishna Kiran Kota  1   4 , Darrel H Higa  1
Affiliations
Meta-Analysis

HIV care outcomes among transgender persons with HIV infection in the United States, 2006-2021

Jeffrey S Becasen et al. AIDS. .

Abstract

Objectives: HIV prevalence is an estimated 14% among transgender women (TW) and 3% among transgender men (TM). HIV care is vital for viral suppression but is hindered by transphobia and HIV stigma. We assessed HIV care outcomes among transgender persons (TG) with HIV in the United States.

Design: Systematic review and meta-analysis of peer-reviewed journal articles.

Methods: We searched multiple electronic databases and Centers for Disease Control and Prevention's HIV Prevention Research Synthesis database for 2006-September 2020. Eligible reports were US-based studies that included TG and reported HIV care outcomes. Random-effects models were used to calculate HIV care outcome rates. The protocol is registered with PROSPERO (CRD42018079564).

Results: Few studies reported outcomes for TM; therefore, only TW meta-analysis results are reported. Fifty studies were identified having low-to-medium risk-of-bias scores. Among TW with HIV, 82% had ever received HIV care; 72% were receiving care, and 83% of those were retained in HIV care. Sixty-two percent were currently virally suppressed. Among those receiving HIV care or antiretroviral therapy (ART), 67% were virally suppressed at last test. Sixty-five percent were linked to HIV care 3 months or less after diagnosis. Seventy-one percent had ever been prescribed ART. Approximately 66% were taking ART, and 66% were ART-adherent. Only 56% were currently adherent the previous year.

Conclusions: HIV care outcomes for TW were not ideal, and research gaps exists for TM. High heterogeneity was observed; therefore, caution should be taken interpreting the findings. Integrating transgender-specific health needs are needed to improve outcomes of transgender persons across the HIV care continuum.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

There are no conflicts of interest.

Figures

Fig. 1.
Fig. 1.
Flowchart of study selection.
See this image and copyright information in PMC

References

    1. CDC. Estimated HIV incidence and prevalence in the United States, 2014–2018. Atlanta, GA: CDC; May 2020.
    1. Eisinger RW, Fauci AS. Ending the HIV/AIDS pandemic. Emerg Infect Dis 2018; 24:413–416. - PMC - PubMed
    1. CDC. Core indicators for monitoring the ending the HIV epidemic initiative. Data reported through December 2019. Atlanta, GA: CDC; March 2020.
    1. Yehia BR, Stewart L, Momplaisir F, Mody A, Holtzman CW, Jacobs LM, et al. Barriers and facilitators to patient retention in HIV care. BMC Infect Dis 2015; 15:246. - PMC - PubMed
    1. Meerwijk EL, Sevelius JM. Transgender population size in the United States: a meta-regression of population-based probability samples. Am J Public Health 2017; 107:e1–e8. - PMC - PubMed

Publication types